
Ranbaxy Laboratories Ltd, India’s top drugmaker by sales, said its Moroccan unit has started functioning, giving it direct access to a $1 billion pharmaceuticals market. The unit, Ranbaxy’s third in Africa, will also help the company supply products to other north African countries in future, it said on Monday. Ranbaxy’s Africa sales rose 23 per cent to $189 million in 2011, it had said last month. The drugmaker, majority owned by Japan’s Daiichi Sankyo, has sales staff of about 1,000 in 44 African countries and makes drugs in Nigeria and South Africa.
GMT 09:47 2018 Tuesday ,23 January
SAP unveils big push into French tech start-upsGMT 05:07 2018 Tuesday ,23 January
Noble Group shares surge 37 percent on buyout talksGMT 19:07 2018 Monday ,22 January
BAKS spent Dh225m on charity projects in 2017GMT 22:52 2018 Sunday ,21 January
French firm "recalls baby milk product"GMT 22:27 2018 Sunday ,21 January
US company plans funds that double bitcoin price movesGMT 21:23 2018 Sunday ,21 January
Pence starts Mideast tour in Egypt amid Arab angerGMT 08:54 2018 Saturday ,20 January
Million-euro bill for firm behind Paris bike-share chaosGMT 10:47 2018 Friday ,19 January
German chemical giant BASF sees 'significant' profit leap

Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Send your comments
Your comment as a visitor